PubRank

Gandhi Damaj

Author PubWeight™ 24.82‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial. Blood 2004 1.78
2 Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program. Blood 2011 1.71
3 Mast cell leukemia. Blood 2012 1.42
4 Multi-drug resistance mediated by P-glycoprotein overexpression is not correlated with ZAP-70/CD38 expression in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 2007 1.40
5 Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma. Hematol J 2004 1.13
6 In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells. Blood 2012 1.10
7 The benefit of induction chemotherapy in patients age > or = 75 years. Cancer 2004 0.98
8 Intensive chemotherapy with thiotepa, busulfan and cyclophosphamide and hematopoietic stem cell rescue in relapsed or refractory primary central nervous system lymphoma and intraocular lymphoma: a retrospective study of 79 cases. Haematologica 2012 0.98
9 SRSF2-p95 hotspot mutation is highly associated with advanced forms of mastocytosis and mutations in epigenetic regulator genes. Haematologica 2014 0.93
10 A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro. PLoS One 2013 0.92
11 Blood CD34-c-Kit+ cell rate correlates with aggressive forms of systemic mastocytosis and behaves like a mast cell precursor. Blood 2011 0.86
12 Mast cell sarcoma: a rare and aggressive entity--report of two cases and review of the literature. J Clin Oncol 2012 0.85
13 Autologous stem cell transplantation in mantle cell lymphoma: a report from the SFGM-TC. Ann Hematol 2013 0.84
14 Gastrointestinal manifestations in mastocytosis: a study of 83 patients. J Allergy Clin Immunol 2013 0.83
15 Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy. PLoS One 2011 0.81
16 L-asparaginase with methotrexate and dexamethasone is an effective treatment combination in blastic plasmacytoid dendritic cell neoplasm. Br J Haematol 2013 0.80
17 Mast Cell Leukaemia: c-KIT Mutations Are Not Always Positive. Case Rep Hematol 2012 0.80
18 Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: A Study From the French Society of Bone Marrow Transplantation and Cellular Therapy. Transplantation 2015 0.78
19 Thalidomide in systemic mastocytosis: results from an open-label, multicentre, phase II study. Br J Haematol 2013 0.78
20 Leukocyte telomere length in mastocytosis: correlations with depression and perceived stress. Brain Behav Immun 2013 0.78
21 Deferasirox and vitamin D improves overall survival in elderly patients with acute myeloid leukemia after demethylating agents failure. PLoS One 2013 0.77
22 Bone complications of mastocytosis: a link between clinical and biological characteristics. Am J Med 2012 0.76
23 Bendamustine is effective in T-cell prolymphocytic leukaemia. Br J Haematol 2014 0.76
24 Relocalization of KIT D816V to cell surface after dasatinib treatment: potential clinical implications. Clin Lymphoma Myeloma Leuk 2012 0.76
25 Mastocytosis among elderly patients: A multicenter retrospective French study on 53 patients. Medicine (Baltimore) 2016 0.75
26 A French National Survey on Clotting Disorders in Mastocytosis. Medicine (Baltimore) 2015 0.75
27 Autologous stem cell transplantation in mantle cell lymphoma: a report from the SFGM-TC. Ann Hematol 2014 0.75
28 [The "lymph node circuit", clinical nursing expertise]. Rev Infirm 2013 0.75
29 High-dose CD34+ cells are not clinically relevant in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell transplantation as compared with standard dose. Transfusion 2002 0.75
30 New insights in the management of patients with hairy cell leukemia. Curr Opin Oncol 2015 0.75
31 [Systemic mastocytosis. Osteoporotic fracture as a manifestation]. Rev Prat 2011 0.75